EUR 148.66 For Business Accounts Only

GSK plc. - Company Profile and SWOT Analysis

Summary

GSK plc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GSK plc. (GSK) discovers, develops, and delivers medicines and vaccines. Its primary offerings include specialty medicines, vaccines, and general medicines that address therapeutic areas such as HIV, respiratory conditions, cancer, immuno-inflammation, antiviral treatments, central nervous system (CNS) disorders, metabolic issues, cardiovascular health, urogenital concerns, antibacterial treatments, dermatology, and rare diseases. GSK also provides over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health, and gastrointestinal conditions. Its vaccine range targets various diseases, including hepatitis, diphtheria, tetanus, whooping cough, rotavirus, HPV infections, measles, and bacterial meningitis, among others. Distributes its products globally through wholesalers, pharmacies, hospitals, physicians, and other organizations. GSK is headquartered in London, England, the UK.

Scope

GSK plc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GSK plc. (GSK) discovers, develops, and delivers medicines and vaccines. Its primary offerings include specialty medicines, vaccines, and general medicines that address therapeutic areas such as HIV, respiratory conditions, cancer, immuno-inflammation, antiviral treatments, central nervous system (CNS) disorders, metabolic issues, cardiovascular health, urogenital concerns, antibacterial treatments, dermatology, and rare diseases. GSK also provides over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health, and gastrointestinal conditions. Its vaccine range targets various diseases, including hepatitis, diphtheria, tetanus, whooping cough, rotavirus, HPV infections, measles, and bacterial meningitis, among others. Distributes its products globally through wholesalers, pharmacies, hospitals, physicians, and other organizations. GSK is headquartered in London, England, the UK.

Reasons To Buy

- Detailed information on GSK plc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GSK plc. in the form of a SWOT analysis
- An in-depth view of the business model of GSK plc. including a breakdown and examination of key business segments
- Intelligence on GSK plc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GSK plc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends